{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:01:04Z","timestamp":1784764864986,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.biopha.2024.117439","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T18:34:29Z","timestamp":1726166069000},"page":"117439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Antibacterial and anti-biofilm activities of new fluoroquinolone derivatives coupled with nitrogen-based heterocycles"],"prefix":"10.1016","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9793-5248","authenticated-orcid":false,"given":"Piotr","family":"Roszkowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3269-9672","authenticated-orcid":false,"given":"Anna","family":"Bielenica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Stefa\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Majewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Markowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Pituch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Koli\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kmiecik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6928-4561","authenticated-orcid":false,"given":"Alicja","family":"Chrzanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Struga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4A","key":"10.1016\/j.biopha.2024.117439_bib1","first-page":"12","article-title":"Mechanisms of action of and resistance to ciprofloxacin","volume":"82","author":"Hooper","year":"1987","journal-title":"Am. J. Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.117439_bib2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s43856-023-00337-2","article-title":"Increase in the community circulation of ciprofloxacin-resistant Escherichia coli despite reduction in antibiotic prescriptions","volume":"3","author":"Tchesnokova","year":"2023","journal-title":"Commun. Med (Lond.)"},{"key":"10.1016\/j.biopha.2024.117439_bib3","doi-asserted-by":"crossref","first-page":"1025633","DOI":"10.3389\/fpubh.2022.1025633","article-title":"The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic","volume":"10","author":"Shariati","year":"2022","journal-title":"Front. Public Health"},{"issue":"30","key":"10.1016\/j.biopha.2024.117439_bib4","doi-asserted-by":"crossref","first-page":"19470","DOI":"10.1039\/D2RA03281C","article-title":"Design and synthesis of hybrid compounds as novel drugs and medicines","volume":"12","author":"Alkhzem","year":"2022","journal-title":"RSC Adv."},{"issue":"17","key":"10.1016\/j.biopha.2024.117439_bib5","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2174\/092986707781058805","article-title":"Molecular hybridization: a useful tool in the design of new drug prototypes","volume":"14","author":"Viegas-Junior","year":"2007","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2024.117439_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00077-17","article-title":"Antibiotic hybrids: the next generation of agents and adjuvants against gram-negative pathogens?","volume":"31","author":"Domalaon","year":"2018","journal-title":"Clin. Microbiol Rev."},{"issue":"3","key":"10.1016\/j.biopha.2024.117439_bib7","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1021\/acsomega.1c05303","article-title":"Ciprofloxacin-tethered 1,2,3-triazole conjugates: new quinolone family compounds to upgrade our antiquated approach against bacterial infections","volume":"7","author":"Agarwal","year":"2022","journal-title":"ACS Omega"},{"issue":"3","key":"10.1016\/j.biopha.2024.117439_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26030624","article-title":"An overview of the synthesis and antimicrobial, antiprotozoal, and antitumor activity of thiazole and bisthiazole derivatives","volume":"26","author":"Borcea","year":"2021","journal-title":"Molecules"},{"issue":"72","key":"10.1016\/j.biopha.2024.117439_bib9","doi-asserted-by":"crossref","first-page":"44247","DOI":"10.1039\/D0RA09198G","article-title":"Prescribed drugs containing nitrogen heterocycles: an overview","volume":"10","author":"Heravi","year":"2020","journal-title":"RSC Adv."},{"issue":"11","key":"10.1016\/j.biopha.2024.117439_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111961","article-title":"The overview on the pharmacokinetic and pharmacodynamic interactions of triazoles","volume":"13","author":"Czyrski","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2024.117439_bib11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejmech.2018.01.078","article-title":"Ciprofloxacin derivatives and their antibacterial activities","volume":"146","author":"Zhang","year":"2018","journal-title":"Eur. J. Med Chem."},{"issue":"9","key":"10.1016\/j.biopha.2024.117439_bib12","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1021\/acs.jmedchem.8b01923","article-title":"Exploitation of antibiotic resistance as a novel drug target: development of a \u03b2-lactamase-activated antibacterial prodrug","volume":"62","author":"Evans","year":"2019","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2024.117439_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27051658","article-title":"Fluoroquinolones' biological activities against laboratory microbes and cancer cell lines","volume":"27","author":"Suaifan","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.biopha.2024.117439_bib14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ejmech.2011.10.049","article-title":"Synthesis of osteotropic hydroxybisphosphonate derivatives of fluoroquinolone antibacterials","volume":"47","author":"McPherson","year":"2012","journal-title":"Eur. J. Med Chem."},{"issue":"4","key":"10.1016\/j.biopha.2024.117439_bib15","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s11030-022-10528-z","article-title":"Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors","volume":"27","author":"Mohammed","year":"2023","journal-title":"Mol. Divers"},{"key":"10.1016\/j.biopha.2024.117439_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejmech.2019.01.072","article-title":"Design and synthesis of aminothiazolyl norfloxacin analogues as potential antimicrobial agents and their biological evaluation","volume":"167","author":"Wang","year":"2019","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.biopha.2024.117439_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejmech.2018.03.026","article-title":"Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity","volume":"150","author":"Kassab","year":"2018","journal-title":"Eur. J. Med Chem."},{"issue":"7","key":"10.1016\/j.biopha.2024.117439_bib18","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00706-018-2215-x","article-title":"Modifications of quinolones and fluoroquinolones: hybrid compounds and dual-action molecules","volume":"149","author":"Fedorowicz","year":"2018","journal-title":"Mon. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2024.117439_bib19","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jiph.2020.02.002","article-title":"Synthesis of novel 2, 3, 5-tri-substituted thiazoles with anti-inflammatory and antibacterial effect causing clinical pathogens","volume":"13","author":"Ahmed","year":"2020","journal-title":"J. Infect. Public Health"},{"issue":"3","key":"10.1016\/j.biopha.2024.117439_bib20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1128\/AAC.44.3.798-801.2000","article-title":"A convenient assay for estimating the possible involvement of efflux of fluoroquinolones by Streptococcus pneumoniae and Staphylococcus aureus: evidence for diminished moxifloxacin, sparfloxacin, and trovafloxacin efflux","volume":"44","author":"Beyer","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.biopha.2024.117439_bib21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1128\/AAC.44.2.304-310.2000","article-title":"Antipneumococcal activities of gemifloxacin compared to those of nine other agents","volume":"44","author":"Davies","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"issue":"21","key":"10.1016\/j.biopha.2024.117439_bib22","doi-asserted-by":"crossref","first-page":"18663","DOI":"10.1021\/acsomega.3c00554","article-title":"N-acylated ciprofloxacin derivatives: synthesis and in vitro biological evaluation as antibacterial and anticancer agents","volume":"8","author":"Struga","year":"2023","journal-title":"ACS Omega"},{"issue":"11","key":"10.1016\/j.biopha.2024.117439_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116261","article-title":"The effect of conjugation of ciprofloxacin and moxifloxacin with fatty acids on their antibacterial and anticancer activity","volume":"23","author":"Chrzanowska","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.117439_bib24","first-page":"14","article-title":"Quinolone antimicrobial agents: mechanism of action and resistance development","volume":"12","author":"Bryan","year":"1989","journal-title":"Clin. Invest Med"},{"issue":"10","key":"10.1016\/j.biopha.2024.117439_bib25","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2024.117439_bib26","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1086\/314056","article-title":"Mechanisms of action and resistance of older and newer fluoroquinolones","volume":"31","author":"Hooper","year":"2000","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.biopha.2024.117439_bib27","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1128\/AAC.44.8.2160-2165.2000","article-title":"Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: different patterns of quinolone-induced inhibition of DNA synthesis","volume":"44","author":"Fournier","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.biopha.2024.117439_bib28","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1128\/AAC.46.11.3370-3380.2002","article-title":"Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone","volume":"46","author":"Ince","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2024.117439_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejmech.2015.04.058","article-title":"Search for factors affecting antibacterial activity and toxicity of 1,2,4-triazole-ciprofloxacin hybrids","volume":"97","author":"Plech","year":"2015","journal-title":"Eur. J. Med Chem."},{"issue":"5","key":"10.1016\/j.biopha.2024.117439_bib30","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.cclet.2016.12.012","article-title":"Conventional and microwave irradiated synthesis, biological activity evaluation and molecular docking studies of highly substituted piperazine-azole hybrids","volume":"28","author":"Mermer","year":"2017","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.biopha.2024.117439_bib31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bioorg.2019.01.009","article-title":"Piperazine-azole-fluoroquinolone hybrids: conventional and microwave irradiated synthesis, biological activity screening and molecular docking studies","volume":"85","author":"Mermer","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2024.117439_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/cbdv.201800261","article-title":"Design, synthesis and antibacterial evaluation of 1-[(1,2)-2-Fluorocyclopropyl]ciprofloxacin-1,2,4-triazole-5(4)-thione Hybrids","volume":"15","author":"Gao","year":"2018","journal-title":"Chem. Biodivers."},{"issue":"18","key":"10.1016\/j.biopha.2024.117439_bib33","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.bmcl.2019.07.041","article-title":"Ciprofloxacin-1,2,3-triazole-isatin hybrids tethered amide: design, synthesis, and anti-mycobacterial activity evaluation","volume":"29","author":"Chen","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2024.117439_bib34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejmech.2016.08.031","article-title":"Design, synthesis and biological evaluation of ciprofloxacin tethered bis-1,2,3-triazole conjugates as potent antibacterial agents","volume":"124","author":"Kant","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.117439_bib35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejmech.2012.11.040","article-title":"Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria","volume":"60","author":"Plech","year":"2013","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.biopha.2024.117439_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102952","article-title":"Design, synthesis and molecular docking of new -4-piperazinyl ciprofloxacin-triazole hybrids with potential antimicrobial activity","volume":"88","author":"Mohammed","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2024.117439_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/14756366.2011.611943","article-title":"Synthesis and biological evaluation of novel benzothiazole clubbed fluoroquinolone derivatives","volume":"28","author":"Sharma","year":"2013","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2024.117439_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/cbdd.12299","article-title":"Discovery of the highly potent fluoroquinolone-based benzothiazolyl-4-thiazolidinone hybrids as antibacterials","volume":"84","author":"Patel","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.biopha.2024.117439_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106975","article-title":"Fluorinated azoles as effective weapons in fight against methicillin-resistance Staphylococcus aureus (MRSA) and its SAR studies","volume":"143","author":"Zhao","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2024.117439_bib40","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s42770-021-00624-x","article-title":"Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies","volume":"52","author":"Rather","year":"2021","journal-title":"Braz. J. Microbiol."},{"issue":"13","key":"10.1016\/j.biopha.2024.117439_bib41","doi-asserted-by":"crossref","first-page":"8441","DOI":"10.1021\/acs.jmedchem.2c01866","article-title":"Design and Synthesis of 4-Fluorophenyl-5-methylene-2(5)-furanone derivatives as potent quorum sensing inhibitors","volume":"66","author":"Zhang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.117439_bib42","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4103\/0971-5916.187114","article-title":"Subinhibitory concentration of ciprofloxacin targets quorum sensing system of causing inhibition of biofilm formation & reduction of virulence","volume":"143","author":"Gupta","year":"2016","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.biopha.2024.117439_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8143739","article-title":"Conjugation of LasR quorum-sensing inhibitors with ciprofloxacin decreases the antibiotic tolerance of clinical strains","volume":"2019","author":"Bortolotti","year":"2019","journal-title":"J. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2024.117439_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03412-23","article-title":"Effects of sub-inhibitory concentrations of nafcillin, vancomycin, ciprofloxacin, and rifampin on biofilm formation of clinical methicillin-resistant Staphylococcus aureus","volume":"12","author":"Park","year":"2024","journal-title":"Microbiol Spectr."},{"issue":"5","key":"10.1016\/j.biopha.2024.117439_bib45","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1021\/acsami.3c14357","article-title":"Ciprofloxacin Poly(beta-amino ester) conjugates enhance antibiofilm activity and slow the development of resistance","volume":"16","author":"Kasza","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"14","key":"10.1016\/j.biopha.2024.117439_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28145311","article-title":"Modification of dispersin B with cyclodextrin-ciprofloxacin derivatives for treating staphylococcal","volume":"28","author":"Abdelkader","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.117439_bib47","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ejmech.2017.06.058","article-title":"Ciprofloxacin-nitroxide hybrids with potential for biofilm control","volume":"138","author":"Verderosa","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.117439_bib48","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c00238","article-title":"Cyanomethylquinolones as a new class of potential multitargeting broad-spectrum antibacterial agents","author":"Tan","year":"2024","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2024.117439_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107086","article-title":"The effects of photoactivated ciprofloxacin and bile acids on biofilms on bile duct catheters","volume":"63","author":"Eberhardt","year":"2024","journal-title":"Int J. Antimicrob. Agents"},{"key":"10.1016\/j.biopha.2024.117439_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115373","article-title":"Antibacterial and antibiofilm activity of permanently ionized quaternary ammonium fluoroquinolones","volume":"254","author":"Fedorowicz","year":"2023","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.biopha.2024.117439_bib51","doi-asserted-by":"crossref","unstructured":"Lipinski, C.A., et al., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings (Reprinted from Advanced Drug Delivery Reviews, vol 23, pg 3-25, 1997). Advanced Drug Delivery Reviews, 2001. 46(1-3): p. 3-26.","DOI":"10.1016\/S0169-409X(96)00423-1"},{"issue":"12","key":"10.1016\/j.biopha.2024.117439_bib52","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2024.117439_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2001741","article-title":"Multidrug-resistant bacteria compensate for the epistasis between resistances","volume":"15","author":"Moura de Sousa","year":"2017","journal-title":"PLoS Biol."},{"key":"10.1016\/j.biopha.2024.117439_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-04045-6","article-title":"Bacterial drug resistance overcome by synthetic restructuring of antibiotics","author":"Mitcheltree","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2024.117439_bib55","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1039\/C5SC03635F","article-title":"Overcoming antibiotic resistance in Pseudomonas aeruginosa biofilms using glycopeptide dendrimers","volume":"7","author":"Michaud","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.biopha.2024.117439_bib56","unstructured":"Wayne, P.A., CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 29th ed. CLSI supplement M100. 2019, Clinical and Laboratory Standards Institute."},{"issue":"8","key":"10.1016\/j.biopha.2024.117439_bib57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10822-023-00511-7","article-title":"OFraMP: a fragment-based tool to facilitate the parametrization of large molecules","volume":"37","author":"Stroet","year":"2023","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"9","key":"10.1016\/j.biopha.2024.117439_bib58","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.160157","article-title":"Exploring the active site of the Streptococcus pneumoniae topoisomerase IV-DNA cleavage complex with novel 7,8-bridged fluoroquinolones","volume":"6","author":"Laponogov","year":"2016","journal-title":"Open Biol."},{"issue":"16","key":"10.1016\/j.biopha.2024.117439_bib59","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2024.117439_bib60","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph"},{"issue":"11","key":"10.1016\/j.biopha.2024.117439_bib61","article-title":"Investigation of the mechanisms of cytotoxic activity of 1,3-disubstituted thiourea derivatives","volume":"14","author":"Strzyga-Lach","year":"2021","journal-title":"Pharm. (Basel)"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224013258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224013258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:04:31Z","timestamp":1784761471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224013258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":61,"alternative-id":["S0753332224013258"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117439","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibacterial and anti-biofilm activities of new fluoroquinolone derivatives coupled with nitrogen-based heterocycles","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117439"}}